Top 25 Companies in Global Anti-Infective Vaccines Development Market: Statistics Report Till 2035
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The global anti-infective vaccines development market refers to the segment of the healthcare and biotechnology industry that focuses on the research, development, and production of vaccines aimed at preventing infectious diseases caused by bacteria, viruses, and other pathogens. The vaccines target children, adults, and elderly people to support immunization programs which hospitals and clinics and public health organizations implement. Anti-infective vaccines provide an effective and preventive approach to disease control which decreases both morbidity and mortality rates while decreasing total healthcare expenses. The market is expanding rapidly because people understand more about immunization and infectious diseases keep increasing and government programs support vaccine research while funding for development grows. Vaccine development now benefits from advances in mRNA vaccines and recombinant vaccines and newly developed delivery systems which improve both vaccine effectiveness and safety and production capacity. The market experiences rapid growth because developing regions need more vaccines and international immunization efforts expand. Health systems use anti-infective vaccines to prepare for pandemics and respond to them because they enable quick defense against new infectious diseases. The global vaccine market shows rising demand for innovation and better access through partnerships between pharmaceutical companies and global health organizations.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti Infective Vaccines Development Market.
Market Segmentation
Global Anti Infective Vaccines Development Market Size, Share, By Vaccine Type (Bacterial Vaccines, Viral Vaccines, and Parasitic Vaccines), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant &Conjugate Vaccines, and mRNA Vaccines), By Route of Administration (Injectable, Oral, and Nasal), By End User (Hospitals, Clinics, Vaccination Centers, and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035
Anti Infective Vaccines Development Market Size & Statistics
- The Market Size for Anti Infective Vaccines Development Was Estimated to be worth USD 6.24 Billion in 2024.
- The Market is Going to Expand at a CAGR of 6.6% between 2024 and 2035.
- The Global Anti Infective Vaccines Development Market Size is anticipated to reach USD 12.6 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Anti Infective Vaccines Development Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Anti Infective Vaccines Development Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the anti infective vaccines development market. The infectious disease outbreak which affects many people together with the population growth in India and China drive the current economic expansion. Government initiatives which are currently on the rise will boost market expansion together with growing vaccination programs and better healthcare facilities. The region experiences accelerated development because of increasing investments which support vaccine research and local manufacturing capabilities.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti Infective Vaccines Development Market.
North America is expected to generate the highest demand during the forecast period in the anti infective vaccines development market. The region's advanced healthcare systems and its substantial healthcare expenditures together with its dominant pharmaceutical companies and ongoing vaccine research funding create this situation. The region experiences increased demand because it has established immunization programs and adopted advanced technologies at an early stage.
Ready to lead the Anti Infective Vaccines Development Market
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Anti Infective Vaccines Development Market
- Rising infectious diseases increasing vaccine demand
- Growth of mRNA and advanced vaccine technologies
- Increasing government immunization programs
- Rising investment in vaccine R&D
- Advancements in vaccine delivery systems
- Expansion in emerging markets (Asia-Pacific)
- Public-private partnerships boosting development
- Use of AI in vaccine research
- Focus on next-generation vaccines
- Increased emphasis on pandemic preparedness
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti Infective Vaccines Development Market.
1. Rising Infectious Diseases
The increasing prevalence of infectious diseases such as influenza, COVID-19, and hepatitis is driving the demand for vaccines worldwide. This growing disease burden is encouraging continuous vaccine development and strengthening global immunization efforts.
2.Growth of mRNA & Advanced Vaccine Technologies
Innovations like mRNA and recombinant vaccine technologies are transforming vaccine development. These technologies enable faster production, improved effectiveness, and better response to emerging infectious diseases.
3.Increasing Government Immunization Programs
Governments across the globe are implementing large-scale vaccination programs and awareness campaigns. These initiatives improve vaccine accessibility, increase coverage, and support overall market growth.
4.Rising Investment in Vaccine R&D
Pharmaceutical companies and governments are increasing investments in research and development. This supports the discovery of new vaccines, enhances existing formulations, and accelerates clinical trials.
5.Advancements in Vaccine Delivery Systems
New delivery methods such as oral, nasal, and needle-free vaccines are improving ease of administration. These advancements enhance patient comfort, increase acceptance, and expand vaccination reach.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the anti infective vaccines development market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti Infective Vaccines Development Market.
Top 25 Companies Leading the Anti Infective Vaccines Development Market
- Pfizer Inc.
- GlaxoSmithKline (GSK) plc
- Merck & Co., Inc.
- Sanofi S.A.
- AstraZeneca plc
- Johnson & Johnson (Janssen)
- Moderna, Inc.
- CSL Limited
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Novartis AG
- Daiichi Sankyo Company, Limited
- Mitsubishi Tanabe Pharma Corporation
- Bavarian Nordic
- Emergent BioSolutions Inc.
- BioNTech SE
- Sinovac Biotech Ltd.
- Sinopharm Group (China National Biotec Group)
- Takeda Pharmaceutical Company Limited
- Biological E. Limited
- Inovio Pharmaceuticals
- Vaxcyte, Inc.
- Novavax, Inc.
- CureVac N.V.
- Valneva SE
1.Pfizer Inc.
Headquarters: New York, USA
Pfizer Inc. is a leading global pharmaceutical company actively involved in the development of anti-infective vaccines. The company focuses on developing vaccines that protect against COVID-19 and pneumococcal infections and influenza. With its research capabilities and worldwide distribution networks, Pfizer helps to raise global vaccination rates. The company's mRNA research has enabled faster vaccine development and improved vaccine effectiveness. Through its ongoing research and development activities, Pfizer works to decrease the worldwide impact of infectious diseases.
2.GlaxoSmithKline (GSK) plc
Headquarters: London, United Kingdom
GSK operates as a key vaccine manufacturer which offers a diverse selection of anti-infective vaccines. The company develops vaccines for diseases such as hepatitis, influenza, and meningitis. GSK uses partnerships and innovation to create better vaccine access throughout the globe. The company's advanced adjuvant systems increase vaccine effectiveness and boost immune system responses.Through its worldwide immunization initiatives, GSK helps to protect public health while stopping disease outbreaks.
3.Merck & Co., Inc.
Headquarters: New Jersey, USA
Merck & Co., Inc. operates as a worldwide healthcare company which showcases its extensive vaccine collection throughout the world. The company develops vaccines for infectious diseases which include HPV and measles and Ebola. Merck introduces new vaccines through its research and innovation efforts which produce better vaccine solutions. The company operates worldwide to deliver its products to customers in every region of the world. Merck provides essential support for preventive healthcare development through its successful vaccination programs.
4.Sanofi S.A.
Headquarters: Paris, France
Sanofi operates as a top pharmaceutical firm which controls a major part of the vaccine industry through its Sanofi Pasteur division. The company develops vaccines for influenza and polio and other infectious diseases. Sanofi focuses on large-scale vaccine production and global supply. The company uses its research capabilities and partnerships to create new vaccines that reach more people. The organization helps improve global health by funding vaccination programs and supporting efforts to control pandemics.
5.AstraZeneca plc
Headquarters: Cambridge, United Kingdom
AstraZeneca develops vaccines as a worldwide biopharmaceutical organization which operates throughout the world. The company gained prominence with its COVID-19 vaccine developed in collaboration with Oxford University. AstraZeneca focuses on creating innovative solutions which provide affordable vaccines to people in all areas of the world. Its strong research pipeline enables the creation of vaccines which protect against multiple infectious diseases. AstraZeneca establishes itself as an essential organization which helps to enhance global health results through its efforts to ensure fair vaccine access.
Are you ready to discover more about the anti infective vaccines development market?
The report provides an in-depth analysis of the leading companies operating in the global anti infective vaccines development market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti Infective Vaccines Development Market.
Company Profiles
1.Pfizer Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
2.GlaxoSmithKline (GSK) plc
3.Merck & Co., Inc.
4.Sanofi S.A.
5.AstraZeneca plc
6.Johnson & Johnson (Janssen)
7.Moderna, Inc.
8.CSL Limited
9.Serum Institute of India Pvt. Ltd.
10.Others
Other Indusrty Reports :
https://www.sphericalinsights.com/reports/germany-electric-bus-market
https://www.sphericalinsights.com/reports/germany-light-commercial-vehicle-market
https://www.sphericalinsights.com/reports/germany-recreational-boating-market
https://www.sphericalinsights.com/reports/germany-surgical-equipment-market
https://www.sphericalinsights.com/reports/furnace-filters-market
Conclusion
The global anti-infective vaccines development market is showing continuous expansion because infectious diseases are becoming more common and vaccine development technology is improving and government immunization programs are providing their support. Anti-infective vaccines deliver economical healthcare solutions which prevent diseases while they decrease healthcare expenses and enhance public health outcomes. The development of mRNA technology and recombinant vaccines together with advanced delivery systems, increase vaccine effectiveness and safety and distribution. The main companies in the market which include pfizer inc. glaxosmithkline (gsk) merck & co. inc. sanofi s.a. and astrazeneca plc, are extending their business activities across different countries, which results in market expansion. The worldwide healthcare systems depend on anti-infective vaccines to control infectious diseases while they maintain essential functions.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?